Medtronic Acquires Nanovis’ Nano-Surface Technology and OsteoSync IP to Advance Next-Gen PEEK Interbody Devices

Officially confirmed, NanovisNano Surface Technology AssetsAnd Sites Medical's OsteoSync Titanium Pad-relatedSome intellectual property has been acquired by Medtronic., for the development of the next generationPEEK Interbody Fusion Device,Further consolidate the latter's leading position in the orthopedic field.

Although the specific financial terms of the deal have not been disclosed, this acquisition undoubtedly highlights Medtronic's ambition in technological layout within niche markets.

Nanovis is a technology-driven company established in 2008, focusing on healing, designing, and manufacturing nano-surface technologies to enhance the biological fixation of orthopedic, spinal, and dental implants.

The company isThe First in the WorldThe company that has obtained FDA approval and next-generation Ti+ PEEK surface technology interbody device (NanoFortiCore) nanotechnology certification is alsoThe world's first and onlyThe company that has obtained FDA approval and the certification for minimally invasive pedicle screw (Nano FortiFix) nanotechnology.

Once named the Best Nanotechnology-Driven Implant Company by Global Health and Pharma, and ranked among the Top Ten Orthopedic Solution Providers by Med Tech Outlook.

Nanovis stated,Its bone growth nanotechnology can enhance the speed and consistency of human bone growth response.It enhances the fixation of the implant through osseointegration. In this process, bone growth occurs and fuses with the surface of the spinal implant.

Nanovis CEO Brian More stated, "We are delighted to collaborate with Medtronic. By integrating our leading nanosurface technology with Medtronic's exceptional PEEK implant designs, we look forward to providing more surgeons with top-tier treatment tools, ultimately benefiting a wide range of patients."

02

What is Nanotechnology?

Nanotechnology refers to the understanding and control of substances approximately 1 to 100 nanometers in size, at which scale the unique properties of materials become apparent and can be utilized to develop new technologies and products.

At the nanoscale, the physical, chemical, and biological properties of materials differ from those of substances at smaller scales, such as atoms, and also from those of substances at larger scales, such as millimeters or inches, which we use in our daily lives.

Nanotechnology involves imaging, measuring, modeling, and manipulating materials that are only a few nanometers in size.

Significant Benefits of Nanotechnology in Orthopedic Implants Include:

The application prospects of nanotechnology in the field of orthopedic implants are broad. By improving biocompatibility, promoting bone tissue regeneration, and enabling targeted drug delivery,Nanotechnology promises safer and longer-lasting implant solutions for patients.

Taking Nanovis's Ti surface technology as an example, its nanotube array structure has been proven to accelerate bone cell growth and significantly enhance the fixation effect of implants.

Ti Surface Technology Features a Controllable Nanostructured Surface Composed of Nanotube Arrays with an Average Pore Size Between 60-80 Nanometers.

Compared with other surfaces commonly used in orthopedics, these nanotube arrays have been shown to increase and accelerate the production of calcified extracellular matrix in human osteoblasts and human mesenchymal stem cells over 21 days in vitro.

Image source: Nanovis official website

From the market perspective, the global orthopedic implants market is experiencing vigorous growth.

With the rapid growth of the global orthopedic implants market (e.g., the average annual compound growth rate in the Chinese market is 17.7%), the application potential of nanotechnology will be further unleashed.

It is precisely based on this technical potential that Medtronic chose to acquire Nanovis to consolidate its leading position in the orthopedics field.

03

After a year of global layoffs and cost-cutting, Medtronic's acquisition activities are reviving.

Less than three months ago (November 21, 2024), Fortimedix Surgical announced that it had been successfully acquired by Medtronic, which is also related to orthopedic technology.

Fortimedix has developed proprietary articulating instrument technology, which it calls "challenging traditional methods." The company aims to set new standards for robotic and non-robotic endoscopic therapeutic interventions and minimally invasive surgery.

According to the Fortimedix website, the company has created a fully laser-cut product architecture, with multi-layer laser-cut tubes nested and welded together. The company states that it transforms low-cost metal tubes into flexible articulating shafts. These shafts have hundreds of moving parts and complex functions when assembled.

The content of this article is for reference only and does not constitute investment advice. Readers are expected to effectively distinguish.If any platform reprints this article, it must take responsibility for the content of the article itself. Medical Device Business Review is not responsible for any impact caused by secondary dissemination after reprinting.

▼More Good Book Recommendations▼